Skip to main content
Richard Cote, MD, Pathology, Saint Louis, MO, Barnes-Jewish Hospital

RichardJCoteMDFRCPath, FCAP

Pathology • Saint Louis, MO

Genitourinary Pathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor and Chair, Department of Pathology and Immunology at Washington Univeristy School of Medicine in St. Louis

Join to view full profile

Dr. Cote is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cote's full profile

Already have an account?

Summary

  • Dr. Richard Cote is the Chair of the Department of Pathology and Immunology at Washington University School of Medicine in St. Louis and is the Chief of the Pathology Service at Barnes-Jewish Hospital. Previously he was Chair of Pathology at University of Miami, and prior to that was a member of the faculty at the University of Southern California Keck School of medicine. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 37 years. He specializes in genitourinary pathology, anatomic pathology, clinical pathology, and surgical pathology and is experienced in breast cancer, genitourinary cancer, prostatectomy, biopsies, and adenocarcinoma.

Education & Training

  • New York University School of Medicine
    New York University School of MedicinePost-Doctoral Fellowship, Postdoctoral Research Fellow, Laboratory of Molecular Pathology (Dr. Angel Pellicer), 1989 - 1990
  • Chief Fellow - Memorial Sloan-Kettering Cancer Center
    Chief Fellow - Memorial Sloan-Kettering Cancer CenterPathology, 1988 - 1990
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Surgical Pathology, 1987 - 1988
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1985 - 1987
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, Research Fellow, Laboratory of Human Tumor Immunology (Dr. Lloyd J. Old) , 1981 - 1983
  • University of Michigan Health System
    University of Michigan Health SystemInternship, Surgical Internship, 1980 - 1981
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • MO State Medical License
    MO State Medical License 2019 - 2025
  • FL State Medical License
    FL State Medical License 2008 - 2025
  • CA State Medical License
    CA State Medical License 1990 - 2022
  • American Board of Pathology Anatomic Pathology

Awards, Honors, & Recognition

  • Saint Louis Magazine Top Doctor Saint Louis Magazine, 2020-2022
  • America's Top Doctors for Cancer Castle Connolly, 2005-2022
  • America's Top Doctors Castle Connolly, 2002-2022
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Obituary: Emil Raphael Unanue, Renowned Immunologist, 88
    Obituary: Emil Raphael Unanue, Renowned Immunologist, 88December 24th, 2022
  • Ravichandran Named BJC Investigator
    Ravichandran Named BJC InvestigatorJune 16th, 2021
  • Genomic Testing Services in Pathology & Immunology Department to Be Expanded
    Genomic Testing Services in Pathology & Immunology Department to Be ExpandedApril 8th, 2021
  • Join now to see all

Grant Support

  • A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancerNIH/National Cancer Institute2018–2023
  • Miami Clinical and Translational Science InstituteNIH2012–2017
  • Culturing Viably Captured Circulating Tumor Cells Using Conditional ReprogrammingNIH/National Cancer Institute2013–2015
  • Development of Laser Mediated Nanodroplet Real-Time PCR on Circulating Tumor Cells (CTC) Captured by Microfilter PlatformDOD2012–2014
  • Integrated Biomarker Profiling for Individualized Prostate Cancer TherapyBankhead-Coley Cancer Research Program2010–2013
  • Integrated Device for Circulating Tumor Cell Capture, Characterization and Lens- Free MicroscopyDepartment of Defense/Breast Cancer Research Program Synergistic Idea Award2009–2012
  • Molecular Analysis of Neoadjuvant Platinum in Triple Negative Breast CancerNIH/National Cancer Institute2009–2012
  • Integrated Microdevice To Capture And Detect Circulating Tumor CellsNational Cancer Institute2010–2011
  • Validation of MAP2K6 as a Therapeutic Target for Metastatic Bladder CancerNIH/National Cancer Institute2009–2010
  • Molecular Analysis Of Neoadjuvant Platinum In Triple Negative Breast CancerNational Cancer Institute2009–2010
  • Circulating Tumor Cell Capture &Analysis In A Multi-Center Prostate Cancer TrialNational Cancer Institute2009–2010
  • Multiplexed Nanosensing For DNA And ProteinsNational Institute Of Biomedical Imaging And Bioengineering2008–2009
  • Multiplexed Nanosensing For DNA And ProteinsNational Institute Of Biomedical Imaging And Bioengineering2007–2008
  • Integrated Microdevice To Capture And Detect Circulating Tumor CellsNational Cancer Institute2006–2007
  • Mcav In Organ-Confined Bladder CA Based On P53 StatusNational Cancer Institute2003–2006
  • Bone Marrow &Sentinel Node Micrometastases In Breast CANational Cancer Institute2000–2004
  • Detection Of Occult Metastases In Lung Cancer PatientsNational Cancer Institute2000–2003
  • Molecular /Cellular Pathways Of Bladder Cancer ProgressionNational Cancer Institute2002
  • Core--PathologyNational Cancer Institute2002
  • Pilot--Genitourinary CancerNational Cancer Institute2001–2002
  • MVAC In Organ-Confined Bladder Cancer Based P53 StatusNational Cancer Institute2001–2002
  • MVAC In Bladder Cancer Based On P53 StatusNational Cancer Institute1999
  • Molecular/Cellular Pathways Of Bladder Ca++ ProgressionNational Cancer Institute1996–1999
  • MVAC In Organ-Confined Bladder Cancer Based On P53 StatuNational Cancer Institute1998
  • Generation And Analysis Of Human Monoclonal AntibodiesNational Cancer Institute1985

Hospital Affiliations

Dr. Richard Cote, Dr. Richard Cote, MD, Dr. R Cote, Dr. Richard J Cote